← Leaderboards
Gregory C Loney
Visby Medical, Inc.
$1,448,379
Attributed
$1,448,379
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $980.7K · FY2017–18$1M$750K$500K$250K$0
'17
'18
Funding mix
By agency
NIH$1,448,379 · 1
By mechanism
R44$1,448,379 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alabama”
- David S. Batey · University Of Chicago$7,018,819
- Jane Grimwood · Hudson-Alpha Institute For Biotechnology$6,999,491
- Ellen Florence Eaton · University Of Alabama At Birmingham$5,658,149
- Gareth John Morgan · Tezcat Laboratories Llc$5,575,548
- Andy Tipton · Alabama State Dept Of Agric & Industries$4,822,687
- Leah Johnson · Research Triangle Institute$4,789,398
Research focus
AlabamaAntibiotic ResistanceAntibioticsBaseBiothreatBusinessesCaringCenters For Disease Control And Prevention (U.S.)ChlamydiaChlamydia InfectionsChlamydia TrachomatisClinicClinical ResearchClinical TrialsCommercializationCostCross ReactivityCurrent Procedural Terminology CodesDetectionDeveloping CountriesDevicesDiagnosticDiagnostic TestsAffect
Grant awards (2)
Commercialization of low cost, disposable, point-of-care molecular diagnostic device for sexually transmitted infections$467,645
R44 · FY2018 · AI · contact PI
Commercialization of low cost, disposable, point-of-care molecular diagnostic device for sexually transmitted infections$980,734
R44 · FY2017 · AI · contact PI